Moderate to Severe Plaque Psoriasis

DBCOND0040433Immune System DiseasesSkin and Subcutaneous Tissue Diseases

Moderate to Severe Plaque Psoriasis is the indication for 5 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Moderate-to-severe Plaque Psoriasis
Classified under
Indicated drugs

What you can answer from here — as of October 22, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
45Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Moderate to Severe Plaque Psoriasis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In